Lv5
960 积分 2025-12-17 加入
Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer
1个月前
已关闭
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)
1个月前
已完结
Metastatic sites and survival in lung cancer
2个月前
已完结
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
2个月前
已完结
Atezolizumab Treatment Beyond Progression in Advanced NSCLC: Results From the Randomized, Phase III OAK Study
2个月前
已完结
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
2个月前
已完结
Comprehensive genomic profiles of small cell lung cancer
2个月前
已完结
Residential radon and small cell lung cancer. A systematic review
2个月前
已完结
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2个月前
已完结
Small-cell lung cancer: what we know, what we need to know and the path forward
2个月前
已完结
皖公网安备34019202002308
